ABSTRACT
There is general recognition that nuclear cardiology, and particularly myocardial perfusion scintigraphy (MPS), is under-utilized in the UK when compared with practice in mainland Europe and the USA. The National Institute for Clinical Excellence (NICE) is about to issue a report that will recognize the shortfall in provision, and this should lead
